Pasithea Therapeutics Corp (KTTA) USD0.0001

Sell:$1.15Buy:$1.19$0.04 (3.54%)

Prices delayed by at least 15 minutes
Sell:$1.15
Buy:$1.19
Change:$0.04 (3.54%)
Prices delayed by at least 15 minutes
Sell:$1.15
Buy:$1.19
Change:$0.04 (3.54%)
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
28 November 2025
Lawrence SteinmanExecutive Chairman
Buy
Regular purchase transaction
133,333$0.75$99,999.75199,691
28 November 2025
Tiago Reis MarquesCEO
Buy
Regular purchase transaction
33,333$0.75$24,999.7573,334
28 November 2025
Simon DumesnilDirector
Buy
Regular purchase transaction
33,333$0.75$24,999.7535,833
28 November 2025
Emer LeahyDirector
Buy
Regular purchase transaction
33,333$0.75$24,999.7533,333
28 November 2025
Daniel H SchneidermanChief Accounting Officer
Buy
Regular purchase transaction
26,667$0.75$20,000.2526,667
12 May 2025
Tiago Reis MarquesCEO
Sell
Regular sell transaction (market)
960$0.83$792.0040,001

End of results. Director deals are only available for the last 12 months.

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
28 November 2025
Lawrence SteinmanExecutive Chairman
Buy
Regular purchase transaction
133,333$0.75$99,999.75199,691
28 November 2025
Tiago Reis MarquesCEO
Buy
Regular purchase transaction
33,333$0.75$24,999.7573,334
28 November 2025
Simon DumesnilDirector
Buy
Regular purchase transaction
33,333$0.75$24,999.7535,833
28 November 2025
Emer LeahyDirector
Buy
Regular purchase transaction
33,333$0.75$24,999.7533,333
28 November 2025
Daniel H SchneidermanChief Accounting Officer
Buy
Regular purchase transaction
26,667$0.75$20,000.2526,667

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.